Navigation Links
Coherent, Inc. Receives Expected Letter from NASDAQ
Date:10/4/2007

SANTA CLARA, Calif., Oct. 4 /PRNewswire-FirstCall/ -- Coherent, Inc. (Nasdaq: COHR) today announced that, as anticipated, on October 1, 2007, it received an additional NASDAQ Staff Determination letter indicating that the Company is not currently in compliance with NASDAQ's listing requirements as set forth in Marketplace Rules 4350(e) and 4350(g) due to its failure to hold an annual meeting of stockholders during its fiscal year ended September 30, 2007. The notice stated that the failure could serve as an additional basis for delisting of the Company's securities.

As previously disclosed, NASDAQ initially informed the Company on December 19, 2006 that its securities would be delisted due to the Company's delay in filing its Form 10-K for the fiscal year ended September 30, 2006 unless the Company requested a hearing in accordance with applicable NASDAQ Marketplace Rules. The Company subsequently requested and was granted a hearing before the NASDAQ Listing Qualifications Panel ("Panel") on February 15, 2007 to request an extension for continued listing on the NASDAQ Global Select Market. On April 3, 2007, the Panel issued a decision granting the Company a conditional extension to file its Form 10-K for the fiscal year ended September 30, 2006, its Form 10-Q for the quarter ended December 30, 2006, and any required restatements. By letter dated May 18, 2007, the NASDAQ Listing and Hearing Review Council ("Listing Council") called the Panel's April 3, 2007 decision for review and determined to stay any decision to suspend the Company's securities pending further action by the Listing Council. Although the Company is working diligently to file its delinquent filings, there can be no assurance that the Listing Cou
'/>"/>

SOURCE Coherent, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Lucigen receives $750K grant to boost biofuel yields
3. Medical College receives $1.4M cancer grant
4. Wisconsin biotech firm receives $107K NIH grant
5. InvivoSciences receives NIH grant for heart technology
6. Medical College receives $11 million grant to study high blood pressure
7. Madison business receives $115,000 of new state biofuels funding
8. Superior receives funds for technical training
9. UWM receives state funding for plastics research
10. GEs Centricity EHR receives federal certification
11. WHIE receives state eHealth Initiative contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013  Personal Genome Diagnostics Inc. (PGDx), ... methodologies and expertise in genomic analysis of defined ... collaboration with Blueprint Medicines.  PGDx is an innovator ... alterations in tumors, and Blueprint Medicines is an ... a genetically defined patient population. "This ...
(Date:5/21/2013)... Ontario (PRWEB) May 21, 2013 ... scientists of the ITN to design the study, ... of two key clinical models used in the ... (EEC) and Nasal Allergen Challenge (NAC) models. Although ... by numerous publications, to date no direct comparison ...
(Date:5/21/2013)... PathoGenetix, Inc., a commercial-stage developer of ... today that it has successfully identified and strain typed ... from the Centers for Disease Control and Prevention (CDC) ... findings are detailed in a poster presented ... Microbiology in Denver on Monday. , The 250 E. ...
(Date:5/20/2013)... UAE (PRWEB) May 21, 2013 ... consultancy specializing in “game-changing” life science and health related ... Dalia Dergham to its International Project Team. Dergham's expertise ... even greater multi-cultural depth to Grace Century as it ... the globe. , Ms. Dergham holds both an under ...
Breaking Biology Technology:Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3Dalia Dergham Joins Grace Century FZ LLC International Project Team 2
... TORONTO, ON - Quantum mechanics is famous for saying that ... there doesn,t make a sound. Quantum mechanics also says that ... tree. And so the famous paradox: how can we ... An international team of researchers, led by University ...
... Genentech and Novartis have the best image among ... market research consultancy that recently completed its 2011 MSImage ... corporate equity and R&D attributes to determine which measures ... growing marketplace. Amgen, Sanofi-aventis and Eli ...
... 2, 2011 Morphotek®, Inc., a subsidiary of Eisai ... phase II study of MORAb-004 for the treatment of ... first-in-class monoclonal antibody that specifically binds to endosialin/tumor endothelial ... safety and therapeutic activity at two dosages. ...
Cached Biology Technology:U of T scientist leads international team in quantum physics first 2U of T scientist leads international team in quantum physics first 3Genentech and Novartis Remain Image Leaders in Oncology and Hematology 2Genentech and Novartis Remain Image Leaders in Oncology and Hematology 3Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 3
(Date:5/21/2013)... Widely available in pharmacies and health stores, phosphatidylserine ... oysters, and soy. Proven to improve cognition and ... older people experiencing memory impairment. Now a team ... Bochner of Tel Aviv University,s Department of ... same supplement improves the functioning of genes involved ...
(Date:5/21/2013)... of biomass experts , Where? Copenhagen, ... 03-07 June 2013 , Why? ... assessment, market and policy developments, manufacturing and installation, drawing ... benefiting from its 2013 edition from a record of ... countries, more than 240 plenary and oral presentations, more ...
(Date:5/20/2013)... Minnesota Medical School researchers from the Masonic Cancer Center, ... Tumor Program, have developed a new mouse model of ... to discover new genes and gene pathways driving this ... week in the journal Nature Genetics . , ... lab of David Largaespada, Ph.D., professor in the Medical ...
Breaking Biology News(10 mins):Common food supplement fights degenerative brain disorders 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4U of M researchers develop model for better testing, targeting of MPNST 2
... combined with an immune-boosting substance called an adjuvant, ... strain of avian influenza (H9N2) provoked a strong ... by the National Institute of Allergy and Infectious ... Health. , The clinical trial of 96 adults ...
... brain cells on a new three-dimensional scaffold of tiny ... body than any other cell culture system. , An ... may one day replace the ubiquitous Petri dish for ... ONE. Shuguang Zhang, associate director of MIT's Center for ...
... Peering deep within the cells of fruit flies, developmental ... University in Philadelphia may have discovered a new way ... If they're right, and the same processes are at ... eventually have implications for improving the understanding of a ...
Cached Biology News:H9N2 avian flu vaccine paired with adjuvant provokes strong human immune response at low doses 2MIT creates 3-D scaffold for growing stem cells 2MIT creates 3-D scaffold for growing stem cells 3Jefferson researchers uncover new way nature turns genes on and off 2
...
...
... 48° Fixed Angle Polypropylene Rotor ... Series, IEC Centra CL3/CL3R** and Centra-MP4/MP4R*. ... quiet operation. /MP4, ,EXCLUSIVE polypropylene rotor ... can be repeatedly autoclaved. Polypropylene ...
The 891 45° Fixed Angle Rotor is designed to provide aerosol containment and can be removed from a centrifuge (seal entact) and opened under an environmental hood....
Biology Products: